Ads
related to: alnylam jobs careersus.jobrapido.com has been visited by 1M+ users in the past month
- Jobs in Phoenix, Az
857 Vacancies available
Don't miss any of them.
- Jobs in New York City, ny
Find the right Opportunity
for You
- Latest Jobs in Florida
Explore all available Vacancies
in your City
- Latest Jobs in Dallas, Tx
763 Vacancies available
in your City. Apply now!
- Jobs in Phoenix, Az
Search results
Results from the WOW.Com Content Network
Alnylam still does not earn money, but writes losses. The losses ("GAAP Operating Loss") from Alnylam were around $650 million in the late 2020. Alnylam expects to achieve net profits financially in 2022 or 2023. [40] In July 2023, Roche partnered with Alnylam Pharmaceuticals in a deal worth $2.8 billion for the development of a hypertension ...
Greenstreet became Alnylam's chief operating officer in 2016. In 2021, it was announced that John Maraganore would step down as Alnylam's CEO on 1 January 2022, and would be succeeded by Greenstreet. [1]
The fifth RNAi therapeutic medicine, AMVUTTRA, was approved in 2021. At Alnylam, he forged over 25 major partnerships with leading pharmaceutical and biotechnology companies, raised over $7.5 billion to fund the company’s research, development, manufacturing, and commercialization activities, and built $25 billion in market capitalization value.
Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY), a biotech company developing a new class of medications based on RNAi technology, have soared 250% since the start of 2013. Why are investors so ...
For premium support please call: 800-290-4726 more ways to reach us
Amy Weinfeld Schulman is an American healthcare biotech venture capitalist, trained as a lawyer, who serves as a managing partner at Polaris Partners. [1] [2] [3] She focuses on investing in healthcare companies and early-stage biotech start-ups.
Ads
related to: alnylam jobs careersus.jobrapido.com has been visited by 1M+ users in the past month